Replacement therapy in the mucopolysaccharidoses.
作者信息
Dean M F
出版信息
J Clin Pathol Suppl (R Coll Pathol). 1978;12:120-7.
Abstract
摘要
相似文献
1
Replacement therapy in the mucopolysaccharidoses.
J Clin Pathol Suppl (R Coll Pathol). 1978;12:120-7.
2
Enzyme replacement therapy in the mucopolysaccharidoses by fibroblast transplantation.
Birth Defects Orig Artic Ser. 1980;16(1):445-56.
3
Enzyme replacement therapy by transplantation of HLA-compatible fibroblasts in Sanfilippo A syndrome.
Pediatr Res. 1981 Jun;15(6):959-63. doi: 10.1203/00006450-198106000-00016.
4
Enzyme replacement therapy by transplantation of HLA-compatible fibroblasts in Sanfilippo syndrome: another trial.
Pediatr Res. 1982 Mar;16(3):259-60. doi: 10.1203/00006450-198203000-00020.
5
[Therapeutic trials in mucopolysaccharidosis].
Minerva Pediatr. 1975 Mar 10;27(8):462-70.
6
A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses.
J Inherit Metab Dis. 1983;6(2):62-81. doi: 10.1007/BF02338973.
7
[Treatment of mucopolysaccharidoses with perfusions of plasma or leukocytes].
Acta Univ Carol Med Monogr. 1973;56:191-5.
8
The treatment of lysosomal storage diseases by fibroblast transplantation: some preliminary observations.
Birth Defects Orig Artic Ser. 1980;16(1):457-74.
9
Arylsulphatase B (Maroteaux-Lamy factor): a part of the enzyme system responsible for sulphate release from mucopolysaccharide fragment.
FEBS Lett. 1976 May 15;65(1):63-8. doi: 10.1016/0014-5793(76)80622-9.
10
New approach to the treatment of mucopolysaccharidoses by plasma and leucocyte transfusions.
Rev Czech Med. 1973;19(2):111-5.
本文引用的文献
1
Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts.
Science. 1971 Jun 18;172(3989):1263-5. doi: 10.1126/science.172.3989.1263.
2
Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion.
Proc Natl Acad Sci U S A. 1971 Feb;68(2):303-7. doi: 10.1073/pnas.68.2.303.
3
In vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources.
Biochem Biophys Res Commun. 1974 Mar 15;57(1):1-8. doi: 10.1016/s0006-291x(74)80349-9.
4
The Hunter corrective factor. Purification and preliminary characterization.
J Biol Chem. 1972 Sep 10;247(17):5456-62.
5
Enzyme replacement in cultured fibroblasts from metachromatic leukodystrophy.
Birth Defects Orig Artic Ser. 1973 Mar;9(2):19-26.
6
A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts.
Biochem Biophys Res Commun. 1974 Mar 15;57(1):55-61. doi: 10.1016/s0006-291x(74)80356-6.
7
A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes.
Biochem Biophys Res Commun. 1972 Nov 15;49(4):992-9. doi: 10.1016/0006-291x(72)90310-5.
8
Infusion of normal HL-A identical leukocytes in Sanfilippo disease type B. Estimate of infused cell survival by assays of alpha-N-acetylglucosaminidase activity and cytogenetic techniques: effect on glycosaminoglycan excretion in the urine.
Arch Neurol. 1974 Nov;31(5):329-37. doi: 10.1001/archneur.1974.00490410077009.
9
Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.
Biochem Biophys Res Commun. 1974 Jul 24;59(2):455-61. doi: 10.1016/s0006-291x(74)80001-x.
10
Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblasts.
J Clin Invest. 1974 Jan;53(1):85-90. doi: 10.1172/JCI107563.
Zotero 插件